Ukraine, Egypt explore preferential trade deal: Zelenskyy    Egypt, Russia's Rosatom review grid readiness for El-Dabaa nuclear plant    Mastercard Unveils AI-Powered Card Fraud Prevention Service in EEMEA Region, Starting from Egypt    Global tour for Korean 'K-Comics' launches in Cairo with 'Hellbound' exhibition    China's factory output expands in June '25    Egyptian pound climbs against dollar at Wednesday's close    New accords on trade, security strengthen Egypt-Oman Relations    Egypt launches public-private partnership to curb c-sections, improve maternal, child health    Gaza under Israeli siege as death toll mounts, famine looms    EMRA, Elsewedy sign partnership to explore, develop phosphate reserves in Sebaiya    Philip Morris Misr announces new price list effective 1 July    Egypt Post discusses enhanced cooperation with Ivorian counterpart    Egypt's Environment Minister calls for stronger action on desertification, climate resilience in Africa    Egypt in diplomatic push for Gaza truce, Iran-Israel de-escalation    Egypt teams up with private sector to boost university rankings    Egypt reveals heritage e-training portal    Three ancient rock-cut tombs discovered in Aswan    Egypt condemns deadly terrorist attack in Niger    Egypt, Tunisia discuss boosting healthcare cooperation        Egypt's EHA, Schneider Electric sign MoU on sustainable infrastructure    Sisi launches new support initiative for families of war, terrorism victims    Grand Egyptian Museum opening delayed to Q4    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Egypt's Irrigation Minister urges scientific cooperation to tackle water scarcity    Egypt discovers three New Kingdom tombs in Luxor's Dra' Abu El-Naga    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    Egypt's Democratic Generation Party Evaluates 84 Candidates Ahead of Parliamentary Vote    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Cabinet approves establishment of national medical tourism council to boost healthcare sector    Egypt's PM follows up on Julius Nyerere dam project in Tanzania    Egypt's FM inspects Julius Nyerere Dam project in Tanzania    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Germany approves first human trials of new coronavirus vaccine
Published in Amwal Al Ghad on 23 - 04 - 2020

Germany's Federal Institute for Vaccines has approved on Wednesday the first human trials of a potential coronavirus vaccine developed by German biotech company BioNTech.
The trial will see 200 healthy participants between the age of 18 and 55 receive several variants of BioNTech's vaccine as scientists examine its efficacy in providing immunity against the virus.
In a second stage, additional tests will be conducted on more people, including those at higher risk from the coronavirus.
Named BNT162, BioNTech said it was developing this vaccine candidate in cooperation with pharmaceutical giant Pfizer.
BNT162 is also expected to be trialled in the U.S., once regulatory approval for testing on humans had been secured there.
To date, the pandemic has killed more than 177,000 people and infected 2.5 million, according to figures from Johns Hopkins University.
There are 86 teams across the globe currently working to develop a coronavirus vaccine, including a handful at the clinical trial stage.
Germany is second country in Europe, after the UK, approving a human trial.
On Tuesday, British health secretary Matt Hancock announced scientists at Oxford University will start testing a vaccine on people this Thursday.
Around 500 volunteers are expected to take part in the programme by mid-May, with the British government pledging £20 million ($1.26 million) to the Oxford research.
Earlier this month, China approved early-stage human tests for two experimental vaccines, according to state media Xinhua.
These Chinese vaccines are being developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech and by the Wuhan Institute of Biological Products, a subsidiary of state-run China National Pharmaceutical Group.
In March, authorities in China approved another clinical trial for a vaccine candidate developed by the Academy of Military Medical Sciences and HK-listed biotech company CanSino Bio.
In the United States, drug developer Moderna has started human tests for their vaccine with the U.S. National Institutes of Health.


Clic here to read the story from its source.